Atlas Trials

Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma

Clinical trial NCT00148317 · COMPLETED

Trial details

NCT number
NCT00148317
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2005-06-01
Primary completion
2011-02-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.